Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
18.4M
-
Shares change
-
+8.27M
-
Total reported value, excl. options
-
$19.3M
-
Value change
-
+$8.55M
-
Put/Call ratio
-
1.89
-
Number of buys
-
50
-
Number of sells
-
-22
-
Price
-
$1.05
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q4 2020
98 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q4 2020.
iBio, Inc. - Common Stock (IBIO) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3.7M shares), GEODE CAPITAL MANAGEMENT, LLC (2.47M shares), STATE STREET CORP (2.11M shares), NORTHERN TRUST CORP (1.95M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.07M shares), PRINCIPAL FINANCIAL GROUP INC (1.02M shares), Nuveen Asset Management, LLC (543K shares), JPMORGAN CHASE & CO (498K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (450K shares), and Bank of New York Mellon Corp (428K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.